Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Corticosteroid therapy is usually regarded as a risk factor for the development of posterior
subcapsular cataracts but prospective studies on this topic and accurate assessment of this
potential adverse effect are lacking. We will evaluate changes of lens transparency after
administration of systemic corticosteroid therapy for at least one year with Scheimpflug
photography and quantification of lens autofluorescence.